Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

TCR and Inflammatory Signals Tune Human MAIT Cells to Exert Specific Tissue Repair and Effector Functions.

Leng T, Akther HD, Hackstein CP, Powell K, King T, Friedrich M, Christoforidou Z, McCuaig S, Neyazi M, Arancibia-Cárcamo CV, Hagel J, Powrie F; Oxford IBD Investigators, Peres RS, Millar V, Ebner D, Lamichhane R, Ussher J, Hinks TSC, Marchi E, Willberg C, Klenerman P.

Cell Rep. 2019 Sep 17;28(12):3077-3091.e5. doi: 10.1016/j.celrep.2019.08.050.

2.

The Short Chain Fatty Acid Butyrate Imprints an Antimicrobial Program in Macrophages.

Schulthess J, Pandey S, Capitani M, Rue-Albrecht KC, Arnold I, Franchini F, Chomka A, Ilott NE, Johnston DGW, Pires E, McCullagh J, Sansom SN, Arancibia-Cárcamo CV, Uhlig HH, Powrie F.

Immunity. 2019 Feb 19;50(2):432-445.e7. doi: 10.1016/j.immuni.2018.12.018. Epub 2019 Jan 23.

3.

CD161 Defines a Functionally Distinct Subset of Pro-Inflammatory Natural Killer Cells.

Kurioka A, Cosgrove C, Simoni Y, van Wilgenburg B, Geremia A, Björkander S, Sverremark-Ekström E, Thurnheer C, Günthard HF, Khanna N; Swiss HIV Cohort Study; Oxford IBD Cohort Investigators, Walker LJ, Arancibia-Cárcamo CV, Newell EW, Willberg CB, Klenerman P.

Front Immunol. 2018 Apr 9;9:486. doi: 10.3389/fimmu.2018.00486. eCollection 2018.

4.

Innate Lymphoid Cells in Intestinal Inflammation.

Geremia A, Arancibia-Cárcamo CV.

Front Immunol. 2017 Oct 13;8:1296. doi: 10.3389/fimmu.2017.01296. eCollection 2017. Review.

5.

Th1 and Innate Lymphoid Cells Accumulate in Primary Sclerosing Cholangitis-associated Inflammatory Bowel Disease.

Gwela A, Siddhanathi P, Chapman RW, Travis S, Powrie F, Arancibia-Cárcamo CV, Geremia A.

J Crohns Colitis. 2017 Sep 1;11(9):1124-1134. doi: 10.1093/ecco-jcc/jjx050.

6.

RORγt inhibitors suppress T(H)17 responses in inflammatory arthritis and inflammatory bowel disease.

de Wit J, Al-Mossawi MH, Hühn MH, Arancibia-Cárcamo CV, Doig K, Kendrick B, Gundle R, Taylor P, Mcclanahan T, Murphy E, Zhang H, Barr K, Miller JR, Hu X, Aicher TD, Morgan RW, Glick GD, Zaller D, Correll C, Powrie F, Bowness P.

J Allergy Clin Immunol. 2016 Mar;137(3):960-3. doi: 10.1016/j.jaci.2015.09.048. Epub 2015 Nov 21. No abstract available.

PMID:
26611672
7.

Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunity.

Paterson AM, Lovitch SB, Sage PT, Juneja VR, Lee Y, Trombley JD, Arancibia-Cárcamo CV, Sobel RA, Rudensky AY, Kuchroo VK, Freeman GJ, Sharpe AH.

J Exp Med. 2015 Sep 21;212(10):1603-21. doi: 10.1084/jem.20141030. Epub 2015 Sep 14.

8.

IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease.

Geremia A, Arancibia-Cárcamo CV, Fleming MP, Rust N, Singh B, Mortensen NJ, Travis SP, Powrie F.

J Exp Med. 2011 Jun 6;208(6):1127-33. doi: 10.1084/jem.20101712. Epub 2011 May 16.

9.

Auto-antibody production and glomerulonephritis in congenic Slamf1-/- and Slamf2-/- [B6.129] but not in Slamf1-/- and Slamf2-/- [BALB/c.129] mice.

Keszei M, Latchman YE, Vanguri VK, Brown DR, Detre C, Morra M, Arancibia-Carcamo CV, Paul E, Calpe S, Castro W, Wang N, Terhorst C, Sharpe AH.

Int Immunol. 2011 Feb;23(2):149-58. doi: 10.1093/intimm/dxq465. Epub 2011 Jan 28. Erratum in: Int Immunol. 2011 Jul;23(7):463. Arancibia, Carolina V [corrected to Arancibia-Carcamo, Carolina V].

10.

Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis.

Izcue A, Hue S, Buonocore S, Arancibia-Cárcamo CV, Ahern PP, Iwakura Y, Maloy KJ, Powrie F.

Immunity. 2008 Apr;28(4):559-70. doi: 10.1016/j.immuni.2008.02.019.

11.

A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism.

Coombes JL, Siddiqui KR, Arancibia-Cárcamo CV, Hall J, Sun CM, Belkaid Y, Powrie F.

J Exp Med. 2007 Aug 6;204(8):1757-64. Epub 2007 Jul 9.

12.

A CIITA-independent pathway that promotes expression of endogenous rather than exogenous peptides in immune-privileged sites.

Arancibia-Cárcamo CV, Osawa H, Arnett HA, Háskova Z, George AJ, Ono SJ, Ting JP, Streilein JW.

Eur J Immunol. 2004 Feb;34(2):471-80.

13.

Gene delivery to the corneal endothelium.

George AJ, Arancibia-Cárcamo CV, Awad HM, Comer RM, Fehevari Z, King WJ, Kadifachi M, Hudde T, Kerouedan-Lebossé C, Mirza F, Barbaros Oral H, Rayner SA, Tan PH, Tay E, Larkin DF.

Am J Respir Crit Care Med. 2000 Oct;162(4 Pt 2):S194-200. Review.

PMID:
11029394
14.

A method for determining the cytoprotective effect of catalase in transiently transfected cell lines and in corneal tissue.

Oral HB, Arancibia-Cárcamo CV, Haskard DO, George AJ.

Anal Biochem. 1999 Feb 1;267(1):196-202.

PMID:
9918671
15.

Lipid-mediated enhancement of transfection by a nonviral integrin-targeting vector.

Hart SL, Arancibia-Cárcamo CV, Wolfert MA, Mailhos C, O'Reilly NJ, Ali RR, Coutelle C, George AJ, Harbottle RP, Knight AM, Larkin DF, Levinsky RJ, Seymour LW, Thrasher AJ, Kinnon C.

Hum Gene Ther. 1998 Mar 1;9(4):575-85.

PMID:
9525318
16.

Lipoadenofection-mediated gene delivery to the corneal endothelium: prospects for modulating graft rejection.

Arancibia-Cárcamo CV, Oral HB, Haskard DO, Larkin DF, George AJ.

Transplantation. 1998 Jan 15;65(1):62-7.

PMID:
9448145

Supplemental Content

Loading ...
Support Center